P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000848048.13001.58 |
| _version_ | 1797287965837230080 |
|---|---|
| author | A. Taghi Khani A. Kumar K. Radecki S. J. Lee A. Sanchez Ortiz M. Lorenson X. Wu J. Koff S. Forman Z. Gu A. Walker S. Swaminathan |
| author_facet | A. Taghi Khani A. Kumar K. Radecki S. J. Lee A. Sanchez Ortiz M. Lorenson X. Wu J. Koff S. Forman Z. Gu A. Walker S. Swaminathan |
| author_sort | A. Taghi Khani |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:42:27Z |
| format | Article |
| id | doaj.art-631adbca50a642ebafe6055fcc9c0384 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:42:27Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-631adbca50a642ebafe6055fcc9c03842024-03-02T03:29:14ZengWileyHemaSphere2572-92412022-06-0161181118210.1097/01.HS9.0000848048.13001.58202206003-01181P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIESA. Taghi Khani0A. Kumar1K. Radecki2S. J. Lee3A. Sanchez Ortiz4M. Lorenson5X. Wu6J. Koff7S. Forman8Z. Gu9A. Walker10S. Swaminathan111 Systems Biology, Beckman Research Institute of City of Hope, Monrovia1 Systems Biology, Beckman Research Institute of City of Hope, Monrovia2 Biomedical Sciences, University of California Riverside, Riverside1 Systems Biology, Beckman Research Institute of City of Hope, Monrovia1 Systems Biology, Beckman Research Institute of City of Hope, Monrovia2 Biomedical Sciences, University of California Riverside, Riverside3 Molecular and Cellular Biology, Beckman Research Institute of City of Hope, Duarte4 Hematology and Medical Oncology, Emory University School of Medicine, Atlanta5 Hematology & Hematopoietic Cell Transplantation, Beckman Research Institute of City of Hope, Duarte, United States of America1 Systems Biology, Beckman Research Institute of City of Hope, Monrovia2 Biomedical Sciences, University of California Riverside, Riverside1 Systems Biology, Beckman Research Institute of City of Hope, Monroviahttp://journals.lww.com/10.1097/01.HS9.0000848048.13001.58 |
| spellingShingle | A. Taghi Khani A. Kumar K. Radecki S. J. Lee A. Sanchez Ortiz M. Lorenson X. Wu J. Koff S. Forman Z. Gu A. Walker S. Swaminathan P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES HemaSphere |
| title | P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES |
| title_full | P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES |
| title_fullStr | P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES |
| title_full_unstemmed | P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES |
| title_short | P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES |
| title_sort | p1296 suppressing synthesis of the long isoform of the prolactin receptor is a targeted strategy to treat autoimmune b lymphoproliferative diseases and b cell malignancies |
| url | http://journals.lww.com/10.1097/01.HS9.0000848048.13001.58 |
| work_keys_str_mv | AT ataghikhani p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT akumar p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT kradecki p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT sjlee p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT asanchezortiz p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT mlorenson p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT xwu p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT jkoff p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT sforman p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT zgu p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT awalker p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT sswaminathan p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies |